Absci and Twist Bioscience Collaborate to Design Novel Antibody Using Generative AI

GlobeNewswireOct 31 20:00

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

GlobeNewswireOct 15 20:00

Absci Started by Guggenheim at Buy on Pioneer Status in AI Drug Design

Seeking AlphaOct 3 01:08

Absci Initiated at Buy by Guggenheim

Dow JonesOct 2 17:57 · Ratings

Guggenheim Initiates Absci Corp(ABSI.US) With Buy Rating, Announces Target Price $10

Futu NewsOct 2 06:31 · Ratings

Is Absci (NASDAQ:ABSI) Using Debt In A Risky Way?

Simply Wall StSep 20 20:49